Jiean Huang
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 8
- Molecular Biology top 10%
- Sphingolipid Metabolism and Signaling 7
- Receptor Mechanisms and Signaling 7
- Protein Kinase Regulation and GTPase Signaling 5
- Cell Biology top 10%
- Caveolin-1 and cellular processes 6
-
- Neuropeptides and Animal Physiology 4
-
- Ferroptosis and cancer prognosis 7
-
- Pancreatic and Hepatic Oncology Research 4
Jiean Huang
62 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 92
- Cancer Research 181
- Molecular Biology 726
- Cell Biology 151
- Cellular and Molecular Neuroscience 127
- Immunology and Allergy 38
Countries citing papers authored by Jiean Huang
This map shows the geographic impact of Jiean Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiean Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiean Huang more than expected).
Fields of papers citing papers by Jiean Huang
This network shows the impact of papers produced by Jiean Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiean Huang. The network helps show where Jiean Huang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jiean Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 4 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 2 | |
| 10 | 2022 | 4 | |
| 11 | 2021 | 22 | |
| 12 | 2020 | 6 | |
| 13 | 2020 | 2 | |
| 14 | 2020 | 6 | |
| 15 | [Down-regulation of sphingosine kinase 1 (SphK1) enhances the chemosensitivity to cisplatin in human colon cancer RKO cells]. | 2017 | 4 |
| 16 | 2017 | 49 | |
| 17 | 2012 | 49 | |
| 18 | 2006 | 68 | |
| 19 | 2006 | 7 | |
| 20 | 2004 | 63 |
About Jiean Huang
Jiean Huang is a scholar working on Cancer Research, Complementary and alternative medicine and Oncology, having authored 68 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), Sphingolipid Metabolism and Signaling (7 papers), Receptor Mechanisms and Signaling (7 papers), Ferroptosis and cancer prognosis (7 papers), Caveolin-1 and cellular processes (6 papers), Protein Kinase Regulation and GTPase Signaling (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Neuropeptides and Animal Physiology (4 papers). The work is most often cited by research in Cancer Research (181 citations), Molecular Biology (726 citations) and Cell Biology (151 citations). Jiean Huang has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Karnam S. Murthy, Mengbin Qin, Sunila Mahavadi, Shiquan Liu, Wimolpak Sriwai, Huiping Zhou, John R. Grider, Wenhui Hu, Chunyan Xu and Li Liang. Their work appears in journals such as PLoS ONE, Biochemical Journal and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.